Zobrazeno 1 - 10 of 484 pro vyhledávání: '"M. L. Disis"'
1
Akademický článek
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer.
Autor: Liu, Shini1,2 (AUTHOR), Deng, Peng1,3 (AUTHOR), Yu, Zhaoliang4 (AUTHOR), Hong, Jing Han5 (AUTHOR), Gao, Jiuping1 (AUTHOR), Huang, Yulin1 (AUTHOR), Xiao, Rong1 (AUTHOR), Yin, Jiaxin1 (AUTHOR), Zeng, Xian1 (AUTHOR), Sun, Yichen6 (AUTHOR), Wang, Peili1 (AUTHOR), Geng, Ruizi7 (AUTHOR), Chan, Jason Yongsheng8 (AUTHOR), Guan, Peiyong9 (AUTHOR), Yu, Qiang5,9 (AUTHOR), Teh, Bin‐Tean5,8,9 (AUTHOR), Jiang, Qingping10 (AUTHOR), Xia, Xiaojun1 (AUTHOR), Xiong, Ying1 (AUTHOR), Chen, Jianfeng1 (AUTHOR)
Publikováno v: Advanced Science. 12/4/2024, Vol. 11 Issue 45, p1-17. 17p.
Zobrazit plný text záznamu
2
Akademický článek
Bioinformatics Analysis and Immunogenicity Assessment of the Novel Multi‐Stage DNA Vaccine W541 Against Mycobacterium Tuberculosis.
Autor: Yang, Yourong1 (AUTHOR), Xue, Yong1 (AUTHOR), Wang, Xiaoou1 (AUTHOR), Wang, Lan1 (AUTHOR), Wang, Jie1 (AUTHOR), Zhang, Junxian1 (AUTHOR), Liu, Yinping1 (AUTHOR), Liang, Yan1 (AUTHOR) amy5919@sina.com, Wu, Xueqiong1 (AUTHOR) xueqiongwu@139.com
Publikováno v: Immunity, Inflammation & Disease. Nov2024, Vol. 12 Issue 11, p1-22. 22p.
Zobrazit plný text záznamu
3
Akademický článek
Polyamine Anabolism Promotes Chemotherapy‐Induced Breast Cancer Stem Cell Enrichment.
Autor: Ji, Guangyu1,2 (AUTHOR), Liu, Jia1 (AUTHOR), Zhao, Zhiqun1 (AUTHOR), Lan, Jie3 (AUTHOR), Yang, You4 (AUTHOR), Wang, Zheng5 (AUTHOR), Feng, Huijing6 (AUTHOR), Ji, Kai7 (AUTHOR), Jiang, Xiaofeng8 (AUTHOR), Xia, Huize1 (AUTHOR), Wei, Guangyao1 (AUTHOR), Zhang, Yajing1 (AUTHOR), Zhang, Yuhong1 (AUTHOR), Du, Xinlong1 (AUTHOR), Wang, Yawen9 (AUTHOR), Yang, Yuanyuan10 (AUTHOR), Liu, Zhaojian2 (AUTHOR), Zhang, Kai9 (AUTHOR) zhangkai@email.sdu.edu.cn, Mei, Qi6,11 (AUTHOR) qimei@tjh.tjmu.edu.cn, Sun, Rong1 (AUTHOR) sunrong@sdu.edu.cn
Publikováno v: Advanced Science. 10/28/2024, Vol. 11 Issue 40, p1-11. 11p.
Zobrazit plný text záznamu
4
IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion
Autor: K. L. Knutson, M. L. Disis
Publikováno v: Clinical and Experimental Immunology. 135:322-329
SUMMARY CD4+ T cells are essential for the immune response against cancer. Vaccination against cancer will likely only be effective at preventing growth of micrometastatic disease while adoptive T cell therapy will be better suited for eradication of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da5ed54753ea91c7fc71c4f71ee8bbe
https://doi.org/10.1111/j.1365-2249.2004.02360.x
Zobrazit plný text záznamu
5
Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines
Autor: M L, Disis, H, Bernhard, F M, Shiota, S L, Hand, J R, Gralow, E S, Huseby, S, Gillis, M A, Cheever
Publikováno v: Blood. 88:202-210
The current studies evaluate granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant. An important issue for developing vaccine therapy for human malignancy is identifying adjuvants that can elicit T-cell responses to proteins
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adfc7f353846eea0e7269483ed1f5c64
https://doi.org/10.1182/blood.v88.1.202.202
Zobrazit plný text záznamu
6
Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein
Autor: M L Disis, J R Gralow, H Bernhard, S L Hand, W D Rubin, M A Cheever
Publikováno v: The Journal of Immunology. 156:3151-3158
HER-2/neu, an overexpressed oncogenic protein, has been proposed as a human cancer vaccine target. HER-2/neu is a "self" protein, however, and methods of vaccine strategies that would be effective in immunizing patients to a "self" tumor Ag have not
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9272475f795ddff2394614d40ce86c80
https://doi.org/10.4049/jimmunol.156.9.3151
Zobrazit plný text záznamu
7
Cancer vaccines targeting the HER2/neu oncogenic protein
Autor: M L, Disis, K, Schiffman
Publikováno v: Seminars in oncology. 28(6 Suppl 18)
Several advances in basic immunology over the last few years have forced a re-evaluation of cancer vaccine development. The most important finding has been that human tumors are immunogenic. The HER2/neu oncogenic protein is a tumor antigen. Existent
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bbb327b3b73570f72383d742ae49dfe7
https://pubmed.ncbi.nlm.nih.gov/11774201
Zobrazit plný text záznamu
8
Clinical translation of peptide-based vaccine trials: the HER-2/neu model
Autor: M L, Disis, K L, Knutson, D G, McNeel, D, Davis, K, Schiffman
Publikováno v: Critical reviews in immunology. 21(1-3)
In the development of targeted cancer immunotherapies, the choice of antigen is obviously critical to the design of any therapeutic strategy, but particularly so for tumor vaccines, which must distinguish malignant cells from normal cells. Investigat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::60a60075609e7451c4679c308c9b197f
https://pubmed.ncbi.nlm.nih.gov/11642608
Zobrazit plný text záznamu
9
Identification of T helper epitopes from prostatic acid phosphatase
Autor: D G, McNeel, L D, Nguyen, M L, Disis
Publikováno v: Cancer research. 61(13)
Helper T cells (Th cells) play a central role in the initiation and maintenance of immune responses, including antitumor immunity. The ability of Th cells in murine models to maintain and enhance the cytolytic efficacy of CD8+ CTLs has led to a renew
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::326ea9887e15fe818f51b10286c6f7e1
https://pubmed.ncbi.nlm.nih.gov/11431355
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje